Monograph
J01DD14 - Ceftibuten |
Propably not porphyrinogenic |
PNP |
Rationale
Probably not significantly metabolised. No data pointing to CYP-interaction. One reference: use with caution.
Chemical description
Betalactamase stable antibiotic of cephalosporine type used in urinary tract infections, exacerbations of chronic bronchitis and in acute sinusitis, otitis media and pharyngotonsillitis where penicillins are ineffective. Metabolized only to a small extent, excreted by the kidneys in unchanged form. No indications for CYP-interaction. South African list: use with caution.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Isocef
© NAPOS 2025